Avanos Medical Stock Analysis

AVNS Stock  USD 19.16  0.21  1.08%   
Avanos Medical is undervalued with Real Value of 22.11 and Target Price of 30.0. The main objective of Avanos Medical stock analysis is to determine its intrinsic value, which is an estimate of what Avanos Medical is worth, separate from its market price. There are two main types of Avanos Medical's stock analysis: fundamental analysis and technical analysis.
The Avanos Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Avanos Medical is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Avanos Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Avanos Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avanos Medical has Price/Earnings To Growth (PEG) ratio of 2.29. The entity had not issued any dividends in recent years. Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Avanos Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 4555 people. For more info on Avanos Medical please contact Michael CPA at 844 428 2667 or go to https://avanos.com.

Avanos Medical Investment Alerts

Avanos Medical generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 673.3 M. Net Loss for the year was (61.8 M) with profit before overhead, payroll, taxes, and interest of 450 M.
Avanos Medical has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Acquisition by Joseph Woody of 80933 shares of Avanos Medical subject to Rule 16b-3

Avanos Medical Upcoming and Recent Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Avanos Largest EPS Surprises

Earnings surprises can significantly impact Avanos Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-05-07
2019-03-310.130.150.0215 
2018-08-07
2018-06-300.170.20.0317 
2021-05-07
2021-03-310.190.230.0421 
View All Earnings Estimates

Avanos Medical Environmental, Social, and Governance (ESG) Scores

Avanos Medical's ESG score is a quantitative measure that evaluates Avanos Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Avanos Medical's operations that may have significant financial implications and affect Avanos Medical's stock price as well as guide investors towards more socially responsible investments.

Avanos Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Neuberger Berman Group Llc2024-06-30
998 K
Tributary Capital Management, Llc2024-06-30
743.1 K
Morgan Stanley - Brokerage Accounts2024-06-30
718.2 K
Royal Bank Of Canada2024-06-30
587.9 K
Prudential Financial Inc2024-09-30
586.7 K
Charles Schwab Investment Management Inc2024-09-30
523.5 K
Northern Trust Corp2024-09-30
502 K
Bank Of New York Mellon Corp2024-06-30
382.2 K
D. E. Shaw & Co Lp2024-09-30
345.7 K
Blackrock Inc2024-06-30
M
Vanguard Group Inc2024-09-30
5.3 M
Note, although Avanos Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avanos Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 890.19 M.

Avanos Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.09)(0.09)
Return On Assets(0.04)(0.03)
Return On Equity(0.05)(0.05)

Management Efficiency

Avanos Medical has return on total asset (ROA) of 0.0208 % which means that it generated a profit of $0.0208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0177 %, meaning that it created $0.0177 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.09). At this time, Avanos Medical's Total Current Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.63 in 2024, whereas Net Tangible Assets are likely to drop slightly above 181.9 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 26.53  32.46 
Tangible Book Value Per Share 4.31  5.47 
Enterprise Value Over EBITDA 23.06  24.21 
Price Book Value Ratio 0.85  1.45 
Enterprise Value Multiple 23.06  24.21 
Price Fair Value 0.85  1.45 
Enterprise ValueB2.3 B
Leadership effectiveness at Avanos Medical is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin
0.0968
Profit Margin
0.023
Beta
0.925
Return On Assets
0.0208
Return On Equity
0.0177

Technical Drivers

As of the 26th of November, Avanos Medical shows the mean deviation of 1.63, and Risk Adjusted Performance of (0.06). Avanos Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Avanos Medical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Avanos Medical is priced correctly, providing market reflects its regular price of 19.16 per share. Given that Avanos Medical has information ratio of (0.14), we suggest you to validate Avanos Medical's prevailing market performance to make sure the company can sustain itself at a future point.

Avanos Medical Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Avanos Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Avanos Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Avanos Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avanos Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avanos Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avanos Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Avanos Medical Outstanding Bonds

Avanos Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avanos Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avanos bonds can be classified according to their maturity, which is the date when Avanos Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Avanos Medical Predictive Daily Indicators

Avanos Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avanos Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Avanos Medical Corporate Filings

13A
14th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F3
6th of November 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
4th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
31st of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
30th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
9th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
31st of July 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
23rd of July 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Avanos Medical Forecast Models

Avanos Medical's time-series forecasting models are one of many Avanos Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avanos Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Avanos Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avanos Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avanos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avanos Medical. By using and applying Avanos Stock analysis, traders can create a robust methodology for identifying Avanos entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.01)(0.01)
Operating Profit Margin 0.01  0.01 
Net Loss(0.09)(0.09)
Gross Profit Margin 0.56  0.37 

Current Avanos Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avanos analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avanos analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
30.0Buy3Odds
Avanos Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Avanos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Avanos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Avanos Medical, talking to its executives and customers, or listening to Avanos conference calls.
Avanos Analyst Advice Details

Avanos Stock Analysis Indicators

Avanos Medical stock analysis indicators help investors evaluate how Avanos Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avanos Medical shares will generate the highest return on investment. By understating and applying Avanos Medical stock analysis, traders can identify Avanos Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow127.7 M
Long Term Debt159.4 M
Common Stock Shares Outstanding46.6 M
Total Stockholder Equity1.2 B
Tax ProvisionM
Quarterly Earnings Growth Y O Y-0.375
Property Plant And Equipment Net144 M
Cash And Short Term Investments87.7 M
Cash87.7 M
Accounts Payable56.3 M
Net Debt121.4 M
50 Day M A21.7336
Total Current Liabilities234.6 M
Other Operating Expenses669.1 M
Non Current Assets Total1.2 B
Non Currrent Assets Other19.3 M
Stock Based Compensation15.8 M

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.